Relief hemostatic ointment for the treatment of hemorrhoids, rectal, 28.4 g, Bayer

Release form, composition and packaging

?

Ointment for rectal and external use is yellow, homogeneous, free of foreign inclusions.

1 g

phenylephrine hydrochloride 2.5 mg (0.25%)

mineral oil - 140 mg (14%), petrolatum - 749 mg (74.9%), methyl parahydroxybenzoate - 2 mg (0.2%), propyl parahydroxybenzoate - 1 mg (0.1%), anhydrous lanolin - 23.5 mg (2.35%), benzoic acid - 2 mg (0.2%), corn oil - 2 mg (0.2%), glycerol - 25 mg (2.5%), lanolin alcohol - 15 mg (1.5%), paraffin - 5 mg (0.5%), purified water - 19 mg (1.9%), thyme herb oil - 1 mg (0.1%), alpha-tocopherol acetate (vit. E) - 0.5 mg (0.05%), white beeswax - 12.5 mg (1.25%).

28.4 g - plastic tubes (1) complete with an applicator - cardboard packs.

pharmachologic effect

Antihemorrhoidal drug.

Phenylephrine hydrochloride is an alpha-adrenergic agonist, has a local vasoconstrictor effect, which helps to reduce exudation, tissue swelling, itching in the anorectal region.

Pharmacokinetics

Data on the pharmacokinetics of Relief® are not provided.

Indications for use

For symptomatic treatment: - hemorrhoids

- cracks in the anus

- anal itching.

Contraindications for use

- hypersensitivity to drug components

- thromboembolic disease

- granulocytopenia.

With care: arterial hypertension, hyperthyroidism, diabetes mellitus, urinary retention (prostatic hypertrophy), pregnancy, lactation.

Dosage regimen

The drug should be used after hygiene procedures.

Adults and children over 12 years of age: remove the protective cap from the applicator.

Attach the applicator to the tube and squeeze out a small amount of ointment to lubricate the applicator.

The ointment is carefully applied through the applicator to the affected areas outside or inside the anus 4 times / day in the morning, evening and after each bowel movement.

After each use, rinse the applicator thoroughly and place it in a protective cap.

The ointment is also applied to the skin in the anus.

Side effect

Rarely: allergic reactions.

Drug interactions

Due to the phenylephrine contained, the effect of antihypertensive drugs is reduced.

With the simultaneous appointment with antidepressants - MAO inhibitors, a hypertensive crisis may develop.

Application during pregnancy and lactation

Use during pregnancy and lactation is not recommended without consulting a doctor.

In case of bleeding, worsening of the condition or in the absence of effect within 7 days, you must stop using the drug and seek medical advice.

Should not be used in conjunction with antihypertensive drugs and MAO inhibitors.

Use in pediatrics Not recommended for use in children under 12 years of age without consulting a doctor.

Name ENG

RELIEF

Clinical and pharmacological group

A drug with anti-inflammatory, wound healing and vasoconstrictor action for local use in proctology

ATX code

Other drugs and their combinations

Dosage

2.5mg / g x 28.4g

Structure

1 g - phenylephrine hydrochloride 2.5 mg (0.25%).

Excipients: mineral oil - 140 mg (14%)

petroleum jelly - 749 mg (74.9%)

methyl parahydroxybenzoate - 2 mg (0.2%)

propyl parahydroxybenzoate - 1 mg (0.1%)

anhydrous lanolin - 23.5 mg (2.35%)

benzoic acid - 2 mg (0.2%)

corn oil - 2 mg (0.2%)

glycerol - 25 mg (2.5%)

lanolin alcohol - 15 mg (1.5%)

paraffin - 5 mg (0.5%)

purified water - 19 mg (1.9%)

thyme herb oil - 1 mg (0.1%)

Vitamin E (alpha-tocopherol acetate) - 0.5 mg (0.05%)

beeswax white - 12.5 mg (1.25%)

Indications

As a symptomatic remedy:

hemorrhoids

cracks in the anus

anal itching.

Contraindications

increased individual sensitivity to drug components

thromboembolic disease

granulocytopenia

children under 12 years of age.,

With care: arterial hypertension, hyperthyroidism, diabetes mellitus, urinary retention (prostatic hypertrophy), pregnancy, lactation.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

INN / Active ingredient

Phenylephrine hydrochloride

Specifications

Category

Hemorrhoids

Scope of the medicinal product

Gastrointestinal tract

Release form

Ointment

Manufacturer country

Greece

Package quantity, pcs

one

Scope of application

Proctology

Minimum age from

No restrictions

Way of introduction

Rectally

Vacation conditions

Without recipe

Brand name

Relief

Components

applicator

The amount of the dosage form in the primary package

28.4 g

Primary packaging type

Tuba

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Hemorrhoid remedy

Dosage form

Ointment for rectal and external use

The target audience

Children

Dosage (volume) of the substance in the preparation

2.5 mg

Expiration date in days

730

Package weight, g

45

Mode of application

:

The drug should be used after hygiene procedures.

Adults and children over 12 years old: remove the protective cap from the applicator, attach the applicator to the tube and squeeze out a small amount of ointment to lubricate the applicator.

Carefully apply the ointment through the applicator to the affected areas outside or inside the anus 4 times a day in the morning, evening and after each bowel movement.

The ointment is also applied to the skin in the anus.

After each use, rinse the applicator thoroughly and place it in a protective cap.

Anatomical and therapeutic characteristics

:

C05AX03 Preparations for the treatment of hemorrhoids and anal fissures in combination

Information on technical characteristics, delivery set, country of manufacture